Table 1.
Comparison of Proportion, Numbers of ISH, SDH and IDH, and recommended medication among population aged ≥45 years (from CHARLS 2011 baseline data).
| Description | 2018 CHL guideline | 2017 ACC/AHA guideline | Difference between CHL and ACC/AHA | |||
|---|---|---|---|---|---|---|
| Proportion | Numbers (95%CI) | Proportion | Numbers (95%CI) | Proportion | Numbers (95%CI) | |
| (95%CI), % | million | (95%CI), % | million | (95%CI), % | million | |
| ISH | ||||||
| ISH in total population | 15.02 | 64.18 | 14.80 | 63.22 | 0.22 | 0.94 |
| (13.28, 16.94) | (57.29, 71.06) | (13.33, 16.40) | (57.97, 68.47) | (-2.37, 2.81) | (10.12, 12.00) | |
| Recommended antihypertensive | 12.00 | 51.24 | 11.73 | 50.10 | 0.27 | 1.14 |
| medication in total population | (10.34, 13.88) | (44.38, 58.11) | (10.80, 12.73) | (45.85, 54.34) | (-1.72, 2.26) | (-7.34, 9.65) |
| IDH | ||||||
| IDH in total population | 2.42 | 10.33 | 6.93 | 29.59 | −4.51 | −19.26 |
| (1.54, 3.77) | (6.25, 14.41) | (6.02, 7.95) | (26.50, 32.68) | (−5.68, −3.34) | (−24.25, −14.26) | |
| Recommended antihypertensive | 2.42 | 10.33 | 3.34 | 14.25 | −0.92 | −3.92 |
| medication in total population | (1.54, 3.77) | (6.25, 14.41) | (2.64, 4.20) | (11.88, 16.62) | (−1.91, 0.08) | (−8.16, 0.34) |
| SDH | ||||||
| SDH in total population | 8.64 | 36.92 | 25.59 | 109.32 | −16.95 | −72.40 |
| (7.51, 9.93) | (31.94, 41.89) | (23.49, 27.81) | (101.05, 117.59) | (NA)1 | (NA)1 | |
| Recommended antihypertensive | 8.64 | 36.92 | 22.24 | 95.00 | −13.60 | −58.08 |
| medication in total population | (7.51, 9.93) | (31.94, 41.89) | (20.35, 24.25) | (86.82, 103.18) | (NA)1 | (NA)1 |
ACC/AHA, American College of Cardiology /American Heart Association; BP, Blood Pressure; CHL, Chinese Hypertension League Guideline; IDH, Isolated Diastolic Hypertension; ISH, Isolated Systolic Hypertension; NA, not applicable; SDH, Systolic and Diastolic Hypertension.
1 95% CI cannot be estimated as SDH by CHL is subset of SDH by ACC/AHA.